Novavax, Inc.
NVAX
Market Cap$967.76M
Close$
$24.78
314.8% upside
Current Fair Value
314.8% upsideUndervalued by 314.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $967.76 Million |
|---|---|
| Enterprise Value | $1.34 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.23 |
| Beta | 3.21 |
| Outstanding Shares | 160,241,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.11 |
|---|---|
| PEG | 70.47 |
| Price to Sales | 1.2 |
| Price to Book Ratio | -1.49 |
| Enterprise Value to Revenue | 1.52 |
| Enterprise Value to EBIT | -4.55 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.67 |
| Debt to Equity | -1.45 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Novavax, Inc.
CEO: Stanley Erck